Bringing the fundamentals into focus…
Back to Intellia Therapeutics, Inc.
How Intellia Therapeutics, Inc. stacks up
NTLA · against 431 other Healthcare companies of similar size
Overall
33/ 100
Near the bottom of its peers.
Ranked #347 of 432 · scores higher than 18% of peers
Bars: peers in each 10-point band of the overall score71 peers with an overall score of 30–39, including NTLA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around NTLA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 1 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 3 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 4 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 5 | 12.3B CNY (≈$1.7B) | 85 | 83 | 86 | 99 | 0 / 2 | |
| 347 | 838M USD | 33 | 59 | 32 | 32 | 2 / 2 | |
| 347 | 841M USD | 33 | 8 | — | 3 | 0 / 2 | |
| 347 | 1.6B USD | 33 | 38 | 28 | 27 | 1 / 2 | |
| 347 | 15.6B DKK (≈$2.3B) | 33 | 50 | 16 | 50 | 2 / 2 | |
| 347 | 1.7B USD | 33 | 8 | 66 | 5 | 1 / 2 | |
| 347 | 966M USD | 33 | 64 | 19 | 39 | 2 / 2 | |
| 347 | 1.3B USD | 33 | 8 | 95 | 12 | 2 / 2 | |
| 347 | 885M USD | 33 | 8 | 99 | 8 | 2 / 2 | |
| 356 | 6.3B CNY (≈$878M) | 32 | 0 | 9 | 26 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score